Journal
CELL DEATH AND DIFFERENTIATION
Volume 17, Issue 12, Pages 1807-1815Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2010.115
Keywords
autophagy; negative regulation; mTOR; Bcl-2; FLIP; p53
Categories
Funding
- United States Public Health Service [CA140964, AI083841]
- Leukemia & Lymphoma Society
- Wright Foundation
- Baxter Foundation
Ask authors/readers for more resources
Autophagy is an evolutionarily conserved catabolic process that involves the invagination and degradation of cytoplasmic components through an autophagosomelysosome track. Autophagy functions as a quality control of cellular milieu and is implicated in a wide variety of pathological conditions. However, excessive or imbalanced autophagic flux may also be associated with cellular toxicity and may potentially contribute to the development of pathological conditions. Just as all membrane trafficking systems need to constantly strike a balance in their level of activation and inhibition to ensure proper spatial and temporal delivery of their cargo, autophagy must also be tightly regulated. Here, we provide an overview of the current knowledge regarding the negative regulation of mammalian autophagy in an effort to understand its physiological relevance and potential clinical importance. Cell Death and Differentiation (2010) 17, 1807-1815; doi:10.1038/cdd.2010.115; published online 24 September 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available